A U.S. patent by Richard a Rothschild with a priority date of 13/10/2015 in the nature of a method provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19 was applied for 4 years prior to the discovery of Covid-19 in a lab in Wuhan China. The priority date of a claim is the date of filing of a specification which first discloses the claimed invention in a manner that is clear enough and complete enough for the invention to be performed.
The filing date of the patent was 17/05/2017. A filing date is the date a patent application is received by the US Patent & Trademark Office (USPTO). Filing dates are important in patent law because they are often used to determine who invented something first and therefore able to hold patent rights to it, such grant shall be for a term beginning on the date on which the patent issues and ending 20 years from the date on which the application for the patent was filed.
How was a patent conceived in 2015 able to provide data analysis for Covid-19, four years prior to Covid-19 break out in Wuhan China?
43 pages, please use the toolbar to download the document.